首页> 美国卫生研究院文献>Implementation Science : IS >Developing the ethics of implementation research in health
【2h】

Developing the ethics of implementation research in health

机译:发展卫生实施研究的伦理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Implementation research (IR) is growing in recognition as an important generator of practical knowledge that can be translated into health policy. With its aim to answer questions about how to improve access to interventions that have been shown to work but have not reached many of the people who could benefit from them, IR involves a range of particular ethical considerations that have not yet been comprehensively covered in international guidelines on health research ethics. The fundamental ethical principles governing clinical research apply equally in IR, but the application of these principles may differ depending on the IR question, context, and the nature of the proposed intervention. IR questions cover a broad range of topics that focus on improving health system functioning and improving equitable and just access to effective health care interventions. As such, IR designs are flexible and often innovative, and ethical principles cannot simply be extrapolated from their applications in clinical research. Meaningful engagement with all stakeholders including communities and research participants is a fundamental ethical requirement that cuts across all study phases of IR and links most ethical concerns. Careful modification of the informed consent process may be required in IR to permit study of a needed intervention. The risks associated with IR may be difficult to anticipate and may be very context-specific. The benefits of IR may not accrue to the same groups who participate in the research, therefore justifying the risks versus benefits of IR may be ethically challenging. The expectation that knowledge generated through IR should be rapidly translated into health policy and practice necessitates up-front commitments from decision-makers to sustainability and scalability of effective interventions. Greater awareness of the particular ethical implications of the features of IR is urgently needed to facilitate optimal ethical conduct of IR and uniform ethical review.
机译:实施研究(IR)越来越受到认可,认为它可以转化为卫生政策,是实用知识的重要生成者。为了回答有关如何改善已证明行之有效但尚未惠及许多可以从中受益的人们的干预措施的问题,IR涉及了一系列尚未在国际上全面涵盖的特殊道德考虑因素。健康研究伦理准则。指导临床研究的基本伦理原则在IR中同样适用,但根据IR问题,背景和拟议干预措施的性质,这些原则的应用可能有所不同。投资者关系问题涵盖了广泛的主题,这些主题侧重于改善卫生系统的功能以及改善公平和公正地获得有效的卫生保健干预措施的机会。因此,IR设计具有灵活性并且经常具有创新性,不能从其在临床研究中的应用简单地推断出道德原则。与所有利益相关者(包括社区和研究参与者)进行有意义的合作是一项基本的道德要求,它贯穿了IR的所有研究阶段,并将大多数道德问题联系在一起。 IR中可能需要仔细修改知情同意程序,以便研究所需的干预措施。与IR相关的风险可能难以预测,并且可能因情况而异。 IR的收益可能不会与参与研究的同一组人产生,因此,从IR的风险和收益进行论证可能在伦理上具有挑战性。通过IR产生的知识应迅速转化为健康政策和实践的期望,要求决策者对有效干预措施的可持续性和可扩展性做出前期承诺。迫切需要进一步了解投资者关系特征的特殊道德含义,以促进投资者关系的最佳道德行为和统一的道德审查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号